EUVIMEDEUVIMED entdecken
Crossref

Lack of regional and whole body sympathetic normalization during antihypertensive drug treatment: a potential link for the residual risk

Guido Grassi, Rita Facchetti, Ana Jelakovic, Cesare Cuspidi

High Blood Pressure & Cardiovascular Prevention · 18.03.2026 · 33 (3) · 351-356

DOI: 10.1007/s40292-026-00786-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift High Blood Pressure & Cardiovascular Prevention, online erschienen am 18.03.2026. Verfasst von Guido Grassi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University Milano-Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy. guido.grassi@unimib.it. Hauptthemen laut MEDLINE: Sympathetic Nervous System, Antihypertensive Agents, Blood Pressure, Essential Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: It is unknown whether the failure of antihypertensive drug treatment to normalize sympathetic cardiovascular (CV) function reported in previous studies selectively affects regional sympathetic CV outflow or it also involves whole body neuroadrenergic drive. AIM: The present study examines the impact of antihypertensive drug treatment on regional and whole body sympathetic CV influences. METHODS: Fifthyfour essential hypertensive patients were included in the study. In each patient measurements consisted of the microneurographic recording of muscle sympathetic nerve traffic (MSNA) and the assay of venous plasma norepinephrine (NE). They were performed before and during an antihypertensive drug treatment (monotherapy or two-drugs combination) prolonged for a 3 months period. Measurements were also carried out in 31 age-matched normotensive controls. RESULTS: In the study population antihypertensive drug treatment lowered clinic blood pressure to values

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sympathetic Nervous SystemAntihypertensive AgentsBlood PressureEssential HypertensionMuscle, SkeletalHypertensionHumansFemaleMaleNorepinephrineMiddle AgedTreatment OutcomeTime FactorsAgedCase-Control StudiesBiomarkersDrug Therapy, CombinationRisk Factors

Stichwörter der Autor:innen

Antihypertensive treatmentHeart rateNorepinephrineResidual cardiovascular riskSympathetic nervous system

Substanzen

Antihypertensive AgentsNorepinephrineBiomarkers

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University Milano-Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy. guido.grassi@unimib.it.
  • Department of Medicine and Surgery, University Milano-Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy.
  • School of Medicine, University Hospital Center Zagreb, University of Rijeka, Rijeka, Croatia.

Zitieren

APA

Grassi, G., Facchetti, R., Jelakovic, A., & Cuspidi, C. (2026). Lack of regional and whole body sympathetic normalization during antihypertensive drug treatment: a potential link for the residual risk. High Blood Pressure & Cardiovascular Prevention, 33(3), 351-356. https://doi.org/10.1007/s40292-026-00786-5

Vancouver

Grassi G, Facchetti R, Jelakovic A, Cuspidi C. Lack of regional and whole body sympathetic normalization during antihypertensive drug treatment: a potential link for the residual risk. High Blood Pressure & Cardiovascular Prevention. 2026;33(3):351-356. doi:10.1007/s40292-026-00786-5

BibTeX
@article{Grassi2026,
  author = {Grassi, Guido and Facchetti, Rita and Jelakovic, Ana and Cuspidi, Cesare},
  title = {Lack of regional and whole body sympathetic normalization during antihypertensive drug treatment: a potential link for the residual risk},
  journal = {High Blood Pressure & Cardiovascular Prevention},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {351--356},
  doi = {10.1007/s40292-026-00786-5}
}
Kostenlos starten →